New hope for advanced ovarian cancer: major trial tests drug to boost chemo
NCT ID NCT06915025
Summary
This large Phase 3 trial is testing whether adding a new drug called IMNN-001 to standard chemotherapy helps people with advanced ovarian, fallopian tube, or primary peritoneal cancer live longer. About 500 participants will be randomly assigned to receive either the standard chemo alone or the chemo plus IMNN-001, which is given directly into the abdomen. The main goal is to see if the combination improves overall survival compared to chemotherapy by itself.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Advent Health
NOT_YET_RECRUITINGOrlando, Florida, 32804, United States
Contact Email: •••••@•••••
Contact
-
Erlanger Health
RECRUITINGChattanooga, Tennessee, 37403, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
Contact
-
Froedtert and The Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
Contact Email: •••••@•••••
Contact
-
Providence Cancer Institute
RECRUITINGPortland, Oregon, 97213, United States
Contact
Contact Email: •••••@•••••
-
Providence Sacred Heart Medical Center & Children's Hospital
RECRUITINGSpokane, Washington, 99204, United States
Contact Email: •••••@•••••
Contact
-
Sanford Health
RECRUITINGSioux Falls, South Dakota, 57104, United States
Contact Email: •••••@•••••
Contact
-
Washington University School of Medicine in St. Louis
RECRUITINGSt Louis, Missouri, 63110, United States
Contact
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.